Abstract:
The invention concerns semi-fluorinated alkanes of the general formulae RFRH or RFRHRF, RF being a linear or branched perfluoroalkyl group and RH being a linear or branched saturated (hydrocarbon)-alkyl group.
Abstract:
A treatment liquid for unfolding detached retina to the chorioid of the eye containing a PFC-mixture whose PFCs are free from C.dbd.C-double bonds and C--H-bonds, with a reduced vapor pressure and a refractive index by virtue of which the PFC/tissue fluid interface is made visible.
Abstract:
A medical aid for the direct transport of at least one drug into lung regions of a patient, wherein provided as the carrier for at least one active substance is at least one semifluorinated alkane in which the at least one active substance is purely physically dissolved in a homogeneous phase.
Abstract:
A process for separation of mixtures of partially- or perfluorinated hydrocarbon compounds, which optionally contain additional chain members from the heteroatom group nitrogen, oxygen, boron, phosphorus and sulfur and/or can be substituted by further halogen atoms, characterized in that such partially- or perfluorinated compounds, which have an acyclic straight-chain structure and a critical molecule diameter in the range from 4 to 7 .ANG. or are substituted by residues with a straight-chain acyclic structure and with a critical molecule diameter in the range from 4 to 7 .ANG., of such partially- or perfluorinated compounds, which have no straight-chain acyclic residues, and whose critical molecule diameter amounts to at least 1.1-fold times the that of the aforementioned straight-chain acyclic residues, in liquid or gaseous phase are separated in that a mixture or a solution of the mixture in an inert organic solvent, the molecular diameter of which is larger that of the aforementioned straight-chain acyclic residue, is contacted with an amount of a molecular sieve sufficient for adsorption, the average pore diameter of which lies in the range of the critical molecule diameter of the aforesaid acyclic residue or up to 30% less, separating the molecular sieve laden predominantly with compounds containing acyclic residues, and desorbing the compounds adsorbed on the molecular sieve.
Abstract:
Use of a biocompatible dye, for example patent blue V or brilliant blue R, for the production of a dye agent for non-cytotoxic visualisation of cells, in particular delimiting or separating membranes in the human or animal body, in particular in the eye.
Abstract:
Described is a method for the purification of perfluorocarbons, or mixtures of perfluorocarbons, having impurities containing hydrogen and/or carbon-carbon double bonds. The impure perfluorocarbons or perfluorocarbon mixtures are reacted with strong aqueous bases in the presence of Ca.sup.2+ or Ba.sup.2+ ions and alcoholate ions together with secondary amines.
Abstract:
The use of perfluorinated heterocyclic compounds of the general formula I, ##STR1## wherein n represents 2-8,X and Y represent a --CF.sub.2 OCF.sub.2 -- group, a --CF.sub.2 --CF.sub.2 --CF.sub.2 -- group or a --CF(CF.sub.3)--CF.sub.2 -- group, andY is a --CF.sub.2 --O--CF.sub.2 -- group, a --CF(CF.sub.3)--CF.sub.2 -- group or a --CF.sub.2 --CF.sub.2 --CF.sub.2 -- group,or mixtures thereof, is described as emulsion-stabilizing additives in medically usable aqueous emulsions of perfluorocarbons, optionally containing hetero atoms, suitable for use in blood substitutes. The compounds are obtained by electrochemical perfluorination.
Abstract:
Use of a composition which contains at least one semifluorinated alkane compound and at least one liquid siloxane, wherein the composition is of a density in a range of 0.8 to 1.5 g/cm3, for preserving organs or limbs.
Abstract translation:使用包含至少一种半氟化烷烃化合物和至少一种液体硅氧烷的组合物,其中所述组合物的密度在0.8至1.5g / cm 3范围内,用于保存器官或四肢。
Abstract:
Use of a composition which contains at least one semifluorinated alkane compound and at least one liquid siloxane, wherein the composition is of a density in a range of 0.8 to 1.5 g/cm3, for preserving organs or limbs.
Abstract translation:使用包含至少一种半氟化烷烃化合物和至少一种液体硅氧烷的组合物,其中所述组合物的密度在0.8至1.5g / cm 3范围内,用于保存器官或四肢。
Abstract:
The invention concerns semi-fluorinated alkanes of the general formulae RFRH and RFRHRF, RF being a linear or branched perfluoroalkyl group and RH being a linear or branched saturated (hydrocarbon)-alkyl group.